Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

Presentation TCT 2025

TCT 69: Optimal P2Y12 inhibitor strategy after acute coronary syndrome: a network meta-analysis of randomised controlled trials

Presenter: Yousif Ahmad

October 28, 2025

Presentation TCT 2025

TCT 772: Optimal Antithrombotic Therapy in Patients with Peripheral Artery Disease: A Systematic Review and Network Meta-analysis of Randomized Clinical Trials

Presenter: Yuriko Hiruma

October 26, 2025

Presentation TCT 2025

Revascularization vs. Optimal Medical Therapy of Chronic Total Occlusions for Symptom Relief and Quality of Life: From the EUROCTO and DECISION-CTO Randomized Trials

Presenter: Gerald S. Werner

October 25, 2025

Presentation TCT 2024

TRISCEND II Trial: Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation

Presenter: Susheel Kodali

October 30, 2024

Presentation TCT 2023

TCT 417: Ten-Year Clinical Outcomes After Randomization to PCI of a Concurrent Chronic Total Coronary Occlusion or Optimal Medical Therapy Alone in Patients With STEMI: Extended Follow-Up of the EXPLORE Trial

Presenter: Anna van Veelen

October 24, 2023

Presentation TCT 2023

Ten-Year Clinical Outcomes after PCI of a Concurrent Chronic Total Coronary Occlusion or Optimal Medical Therapy Alone in Patients with STEMI: Extended Follow-Up of the EXPLORE trial

Presenter: Anna van Veelen

October 23, 2023

Presentation TCT 2022

TCT 199: A Symptom-Stratified Analysis of the Objective Randomised Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina Trial

Presenter: Rachel Pathimagaraj

September 18, 2022

Presentation TCT 2021

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From FDA Perspective

Presenter: Meir Shinnar

November 05, 2021

Presentation TCT 2021

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From Academic Perspective

Presenter: William Abraham

November 05, 2021

Presentation TCT 2020

TCT 377: Initial Optimal Medical Therapy With or Without Invasive Strategy for Stable Coronary Disease: A Meta-analysis and Systematic Review

Presenter: Mahmoud Barbarawi

October 14, 2020

Presentation TCT 2019

The Case for Optimal Medical Therapy First in Most!

Presenter: William Boden

September 27, 2019

Presentation TCT 2019

What Is Optimal Medical Therapy for CLI? Can We Move the Needle With Drugs Alone?

Presenter: Marc Bonaca

September 25, 2019

Presentation TCT 2018

Optimal Medical Therapy of Patients With Critical Limb Ischemia

Presenter: Ehrin J. Armstrong, Sahil A. Parikh, Douglas E. Drachman

September 22, 2018

Presentation TCT 2018

Optimal Medical Therapy With and Without Coronary Revascularization: Which Drugs Matter? Symptoms, Ischemia, or Prognosis? And Magnitude of Impact

Presenter: David J. Cohen, Sunil V. Rao, David J. Maron

September 22, 2018

Presentation TCT 2015

Optimal Medical Therapy After PCI: What Is Optimal, and What Is Realistic?

Presenter: Bernard J. Gersh, Stephen D. Wiviott, David J. Maron

October 13, 2015

Presentation TCT 2012

The impact of revascularization and optimal medical therapy on six-month clinical outcome in patients with and without congestive heart failure after acute myocardial infarction

Presenter: Jang Hoon Lee, Kyun Hee Kim, Won Suk Choi, Sun Hee Park, Myung Hwan Bae, Dong Heon Yang, Hun Sik Park, Yongkeun Cho, Shung Chull Chae, Jae Eun Jun, Myung Ho Jeong, Young Jo Kim

January 03, 2012

Advertisement

TCT 69: Optimal P2Y12 inhibitor strategy after acute coronary syndrome: a network meta-analysis of randomised controlled trials

TCT 772: Optimal Antithrombotic Therapy in Patients with Peripheral Artery Disease: A Systematic Review and Network Meta-analysis of Randomized Clinical Trials

Revascularization vs. Optimal Medical Therapy of Chronic Total Occlusions for Symptom Relief and Quality of Life: From the EUROCTO and DECISION-CTO Randomized Trials

TRISCEND II Trial: Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation

TCT 417: Ten-Year Clinical Outcomes After Randomization to PCI of a Concurrent Chronic Total Coronary Occlusion or Optimal Medical Therapy Alone in Patients With STEMI: Extended Follow-Up of the EXPLORE Trial

Ten-Year Clinical Outcomes after PCI of a Concurrent Chronic Total Coronary Occlusion or Optimal Medical Therapy Alone in Patients with STEMI: Extended Follow-Up of the EXPLORE trial

TCT 199: A Symptom-Stratified Analysis of the Objective Randomised Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina Trial

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From FDA Perspective

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From Academic Perspective

TCT 377: Initial Optimal Medical Therapy With or Without Invasive Strategy for Stable Coronary Disease: A Meta-analysis and Systematic Review

The Case for Optimal Medical Therapy First in Most!

What Is Optimal Medical Therapy for CLI? Can We Move the Needle With Drugs Alone?

Optimal Medical Therapy of Patients With Critical Limb Ischemia

Optimal Medical Therapy With and Without Coronary Revascularization: Which Drugs Matter? Symptoms, Ischemia, or Prognosis? And Magnitude of Impact

Optimal Medical Therapy After PCI: What Is Optimal, and What Is Realistic?

The impact of revascularization and optimal medical therapy on six-month clinical outcome in patients with and without congestive heart failure after acute myocardial infarction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content